9th July 2019
Selected participants have completed the first week of the programme, delivered by Imperial College London
The first week of the Imperial College and Vlerick Business School Boot Camp, which reached its conclusion on 1 September, focused on problem solving. Throughout the week, participants assessed the full potential impact of their technology or idea and how it creates better and healthier lives. They carried out field research to assess the value of their idea, how it could benefit patients and improve process. In addition, they also worked on their communication skills by testing themselves in the Imperial Impact LabTM.
Participants who joined the programme have been actively working on an idea they believe could change the future of the health industry. The boot camp consists of two stages and takes place in two locations – London and Leuven. Throughout the boot camp, participants explore frameworks and concepts and apply them to their idea. As they build their business plan, world-class industry experts and academics will challenge it – helping them turn it into a robust, commercial offer.
The boot camp includes three content blocks:
- One: Value Creation in Health Markets
- Two: Value Capture
- Three: Value Delivery
After each block, they will have the opportunity to refine their idea with the help of coaches and experts. They will also present their idea to fellow participants and get valuable feedback.
Throughout their journey they will get expert support and insight both from faculty and industry partners –Johnson & Johnson and UCB – who co-fund and support this programme.
This programme is a partnership between the Health Sciences & Business Institute of KU Leuven and Vlerick Business School – and Imperial College London, a core partner of EIT Health UK-Ireland.
Imperial College Business School is also involved in the Advanced Management Program in Health Innovation (AMP Health Innovation), in collaboration with IESE Business School and Copenhagen Business School, which started on 3rd July and will continue until 30th November.
EIT Health helps Tubulis secure €10.7M in funding
Investor Network aids firm doing antibody work
EIT Health-backed start-ups garner big investments
A million each for iLoF and Restorative Neurotechnologies
EIT Health aids 11 start-ups disrupted by COVID-19
Start-up Rescue Instrument gives €5.5M in co-investment